Australia Markets closed

Lumos Pharma, Inc. (LUMO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.85+0.25 (+3.29%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 0.92
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 312.05
52-week low 36.15
50-day moving average 38.67
200-day moving average 38.84

Share statistics

Avg vol (3-month) 313.69k
Avg vol (10-day) 38.71k
Shares outstanding 58.36M
Implied shares outstanding 6N/A
Float 85.04M
% held by insiders 133.47%
% held by institutions 132.33%
Shares short (28 Apr 2022) 418.23k
Short ratio (28 Apr 2022) 41
Short % of float (28 Apr 2022) 40.30%
Short % of shares outstanding (28 Apr 2022) 40.22%
Shares short (prior month 30 Mar 2022) 420.94k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Mar 2020
Ex-dividend date 4N/A
Last split factor 21:9
Last split date 318 Mar 2020

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-13,629.13%

Management effectiveness

Return on assets (ttm)-17.08%
Return on equity (ttm)-29.61%

Income statement

Revenue (ttm)230k
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)450.00%
Gross profit (ttm)230k
EBITDA -31.07M
Net income avi to common (ttm)-30.43M
Diluted EPS (ttm)-3.27
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)94.81M
Total cash per share (mrq)11.34
Total debt (mrq)557k
Total debt/equity (mrq)0.63
Current ratio (mrq)19.43
Book value per share (mrq)11.26

Cash flow statement

Operating cash flow (ttm)-29.65M
Levered free cash flow (ttm)8.17M